Home › Funds › Casdin Capital › EWTX

Casdin Capital position in EWTX

EDGEWISE THERAPEUTICS INC · Health Care

Casdin Capital reported holding 265,000 shares of EWTX (EDGEWISE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$10.8M, representing 0.47% of its reported portfolio and ranking #31 among its reported holdings. Casdin Capital first reported this position in Q3 2026.

Latest position (Q3 2026)265.00K sh
Reported value held$10.76M
Portfolio Weight0.47%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Casdin Capital's EWTX position evolved

Casdin Capital first disclosed a stake in EWTX in Q3 2026 at 265,000 shares (US$10.8M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 265.00K $10.76M New

About EWTX and 13F data

EWTX (EDGEWISE THERAPEUTICS INC) is a Health Care company. 44 other funds we track also report a position in EWTX — the largest reported positions include ORBIMED ADVISORS LLC (US$630.1M), Paradigm Biocapital Advisors LP (US$437.6M), RA CAPITAL MANAGEMENT, L.P. (US$340.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EWTX

All EWTX fund holders →

FAQ

How long has Casdin Capital held EWTX?

Casdin Capital has disclosed EWTX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Casdin Capital's current position in EWTX?

As of Q3 2026, Casdin Capital holds 265.00K shares of EWTX (EDGEWISE THERAPEUTICS INC), valued at $10.76M, representing 0.47% of its reported portfolio and ranking #31.

Has Casdin Capital been buying or selling EWTX?

In the latest 13F filing (Q3 2026), Casdin Capital newly opened its position in EWTX.

Which other funds hold EWTX?

Other major institutional holders of EWTX include ORBIMED ADVISORS LLC, Paradigm Biocapital Advisors LP, RA CAPITAL MANAGEMENT, L.P., among 44 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.